Skip to main content Skip to navigation

Single-Cell Multiomics Uncovers Hidden Dendritic Cell Populations to Inform Development of Immunotherapeutics

Watch On-Demand

Combining Single-cell RNA-seq and Proteomics

 

Monocyte-derived dendritic cell-based therapeutic vaccine platforms have been widely evaluated in clinical trials, yet conventional maturation protocols often yield cells with limited IL-12p70 secretion and suboptimal cytotoxic T-cell priming. Alpha-type-1-polarized dendritic cells (αDC1) offer an alternative approach, leveraging type 1 and type 2 interferon-based maturation to enhance IL-12p70 production and drive robust Th1 immunity. While these αDC1 cells appear uniform under traditional analysis, advanced single-cell techniques reveal hidden complexity that may explain variable vaccine effectiveness.


This webinar will share preliminary findings from work at the Mailliard Lab at the University of Pittsburgh School of Medicine using scRNA-seq on the BD Rhapsody™ System combined with the BD OMICS-One™ APC Protein Panel and BD® AbSeq Antibody-Oligos to profile 42 surface markers. These data uncover multiple functionally distinct αDC1 subpopulations, each secreting unique immunomodulatory cytokines and chemokines. These insights shed light on how dendritic cell subsets orchestrate immune responses and suggest mechanisms underlying individual differences in vaccine outcomes. Identifying protein markers that distinguish these subsets will enable isolation and deeper characterization of their therapeutic potential.


Key takeaways:
 

  • How combined RNA and protein analysis enhances dendritic cell characterization
  • Insights into specialized αDC1 subpopulations and their immunomodulatory roles
  • Strategies for improving dendritic cell-based vaccine design and T-cell priming

 

 

Speaker

 

Ally DePuyt, PhD candidate

Mailliard Lab, Department of Infectious Diseases and Microbiology

University of Pittsburgh School of Public Health
 

Ally DePuyt is a doctoral candidate in Robbie Mailliard’s lab in the Division of Infectious Diseases at the University of Pittsburgh School of Medicine. She received her bachelor’s degree in cellular neuroscience from Colgate University, where she studied the anti-inflammatory effects of antidepressant medications on microglia and astrocytes. She then completed a post-baccalaureate fellowship in Miles Herkenham’s lab at the National Institute of Mental Health where she evaluated the impact of chronic psychological stress on innate immune dynamics at the blood-brain barrier. Her current research focuses on the use of dendritic cells as immunotherapeutics to promote long-term control of HIV-1.

  

 

Access the on-demand webinar


*Required fields

   

   

For Research Use Only. Not for use in diagnostic or therapeutic procedures.